UNH Price Prediction Next Week
Analysis and Insights
Fundamental Analysis:
UnitedHealth Group (UNH) has shown strong fundamentals, with a 69% rating from Validea's Growth Investor model, indicating persistent growth in earnings and sales. The company's strategic move to adopt a cost-based reimbursement model through Optum Rx is expected to enhance its market position and financial outlook, with projected revenues between $145.5 billion and $146.5 billion for 2025.
Technical Analysis:
UNH's stock shows a bullish trend with an RSI of 80.24, indicating overbought conditions. The MACD is positive, but the histogram shows a decline in momentum. Fibonacci levels suggest a pivot point at 496.39, with resistance at 513.20 and 523.58.
Price Prediction:
Given the strong fundamentals and bullish trend, UNH is expected to reach $522 by the end of the next trading week.
Recommendation:
Buy UnitedHealth Group (UNH) at current levels, targeting the next resistance level of $523.58.
UNH Similar Chart Price Prediction
The price of UNH is predicted to go up -8.16%, based on the high correlation periods with NISN. The similarity of these two price pattern on the periods is 97.17%.
UNH
NISN
Down: -8.16%Similarity: 97.17%
UNH Stock Forecast & Prediction For Years 2025, 2026, 2027, 2028, 2029 and 2030
Year
UNH Price Forecast($)
Potential Return(%)
2025
513.520
0.100
2026
650.000
36.850
2027
650.000
36.850
2028
822.000
73.070
2029
750.000
57.910
2030
850.000
78.960
What is UNH stock price prediction 2025 ?
What is UNH stock price prediction 2026 ?
What is UNH stock price prediction 2027 ?
What is UNH stock price prediction 2028 ?
What is UNH stock price prediction 2029 ?
What is UNH stock price prediction 2030 ?
UNH Revenue Forecast
UNH EPS Forecast
UNH FAQs
What is UNH revenue forecast for next quarter？
What is UNH eps forecast for next quarter？
UNH VS S&P500
UnitedHealth's strategy of providing medical insurance, pharmacy benefits, and healthcare services creates a powerful alignment of incentives that should help clients control their healthcare costs better than pure-play competitors.
As the leading provider of Medicare Advantage plans in the U.S., UnitedHealth should benefit from ongoing demographic shifts and the increasing popularity of these plans among seniors.
UnitedHealth has managed its balance sheet more conservatively than peers, giving it more flexibility in times of change.
UNH Analyst's Forecast
Andrew Mok
Barclays
Buy
2025-01-17
Price Target
$655 → $642
Upside
+25.94%
Barclays lowered the firm's price target on UnitedHealth to $642 from $655 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q4 report. It estimates one-third of the 80-90 basis point one-time medical loss ration headwind is driven by Medicare Advantage rebates.
David Macdonald
Truist Securities
Strong Buy
2025-01-06
Price Target
$625 → $610
Upside
+18.75%
Jessica Tassan
Piper Sandler
Buy
2025-01-02
Price Target
$605 → $600
Upside
+18.93%
